Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here